`U.S. Patent 10,335,462
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`MYLAN PHARMACEUTICALS, INC.,
`Petitioner
`
`v.
`
`NOVO NORDISK A/S,
`Patent Owner
`______________________
`Case IPR2023-00724
`Patent 10,335,462
`______________________
`
`
`
`DECLARATION OF SMITA AGARWAL
`
`
`
`
`
`Novo Nordisk Exhibit 2053
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00001
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`
`
`I, Smita Agarwal, declare as follows:
`
`1. My name is Smita Agarwal. I am above the age of 18 and reside in
`
`Lawrenceville, NJ. I have personal knowledge of the facts set forth in this
`
`Declaration. All statements herein made of my own knowledge are true and all
`
`statements made on information and belief are believed to be true.
`
`2. My current employer is Novo Nordisk Inc. (“Novo Nordisk”). My job
`
`title is Senior Analyst-Data Management. As part of my job responsibilities, I
`
`review and analyze data from many sources, including from IQVIA. Data from
`
`IQVIA is used and kept by Novo Nordisk in the ordinary course of our business and
`
`regularly relied upon by individuals within Novo Nordisk.
`
`3.
`
`Exhibit 2301 is a true and correct copy of data that I exported from
`
`IQVIA’s database on or about January 12, 2024.
`
`
`
`Having been warned that willful false statements and the like are punishable
`
`by fine or imprisonment, or both (18 U.S.C. 1001) and may jeopardize the validity
`
`of the patent at issue in this proceeding, I declare under penalty of perjury under the
`
`laws of the United States of America that the foregoing is true and correct.
`
`
`
`Executed on: January 12, 2024 /Smita Agarwal/
`
`
`
`
`
`
`
`
`
`
`
`
`
`Smita Agarwal
`
`1
`
`
`
`
`
`Novo Nordisk Exhibit 2053
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00002
`
`